Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine.  [electronic resource] 

 -  International orthopaedics  1999 
 - 73-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0341-2695 
<br/><br/><label>Standard No.: </label>10.1007/s002640050311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Ambulatory Care--methods<br/>Aminosalicylic Acid--therapeutic use<br/>Antitubercular Agents--therapeutic use<br/>Bone Transplantation<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Drug Therapy, Combination<br/>Ethambutol--therapeutic use<br/>Female<br/>Humans<br/>Infant<br/>Isoniazid--therapeutic use<br/>Male<br/>Middle Aged<br/>Osteotomy--methods<br/>Radiography<br/>Rifampin--therapeutic use<br/>Streptomycin--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Tuberculosis, Spinal--diagnostic imaging